ArticleEuropean heart journal. Case reports2025
Loeffler endocarditis in hypereosinophilic syndrome, the paradox of absent peripheral eosinophilia: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Loeffler endocarditis is a cardiac disease characterized by infiltration of eosinophils in hypereosinophilic syndrome (HES), progressing through acute necrotic, thrombotic, and fibrotic stages. It can ultimately lead to heart failure and restrictive cardiomyopathy. Early recognition, multidisciplinary approach, and accurate treatment are crucial to prevent these complications. Case summary: A 51-year-old man presented with dyspnoea and chest discomfort. Imaging revealed a large left ventricular (LV) thrombus, a reduced LV ejection fraction (LVEF 28%), and a typical 'double-V pattern' of endomyocardial fibrosis. Despite characteristic imaging findings of Loeffler endocarditis, the absence of peripheral eosinophilia reduced clinical suspicion. Coronary disease was excluded by CT coronary angiography. Extended bloodwork for infectious, autoimmune, oncologic, and HES-related diseases remained negative. Myeloperoxidase tested positive; however, there were no clinical findings suggestive of eosinophilic granulomatosis with polyangiitis. Subsequently, a bone marrow biopsy confirmed eosinophilia, establishing the diagnosis of Loeffler endocarditis. The patient was treated with anticoagulation, heart failure therapy, and prednisone. At 6-month follow-up, LVEF improved slightly to 35% but the typical V-shaped LV thrombus persisted, and heart failure symptoms (NYHA III) remained. Discussion: Loeffler endocarditis is an eosinophil-mediated disease but may present without peripheral eosinophilia, particularly in longstanding cases of HES. This underscores the importance of cardiac imaging, bone marrow evaluation, and multidisciplinary collaboration in suspected cases to ensure timely diagnosis and treatment, thereby preventing disease progression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.